After decades of trials and developments, biotechnology has delivered highly efficient drugs. Life threatening diseases, such as some aggressive cancers, can be managed by patients in the long term. In addition, we see an unprecedented increase of non-communicable diseases, such as diabetes, possibly caused by modern lifestyles, including poor nutritional diets.

Skyviews Life Science is specifically designed to identify investment opportunities in companies at the growing interface between biotechnology, molecular nutrition and digital platforms that prevent the onset and facilitate the management of chronic conditions.

We invest into private and public companies with better drugs, advanced technology platforms, preventive strategies, personalized solutions and more natural foods that will improve people’s quality of life.